Presbia’s Flexivue Microlens® Receives Approval for Patient Implantation in Brazil

Published: Oct 19, 2011

AMSTERDAM--(BUSINESS WIRE)--Presbia, a medical device company and leader in near vision restoration, announced today that it has received medical device registration approval in Brazil for the Flexivue Microlens®, a safe, effective, reliable, and reversible treatment for presbyopia that eliminates dependence on reading glasses or contact lenses for seeing near objects. This approval adds to the growing list of more than 40 countries across Europe, Latin America and the Middle East where the Flexivue is now commercially available.

Back to news